SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Remedium Lifecare - Quaterly Results

27 May 2024 Evaluate
The Total revenue for the quarter ended March 2024 of  Rs. 14084.94 millions grew by 1763.58% from Rs. 755.80 millions.The Net Loss for the quarter ended March 2024 is Rs. -537.20 millions as compared to Net Loss of Rs. -47.82 millions of corresponding quarter ended March 2023 Operating profit Margin for the quarter ended March 2024 further decreased to -321.35% as compared to -28.97% of corresponding quarter ended March 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 14084.94 755.80 1763.58 40417.07 5098.37 692.74 40417.07 5098.37 692.74
Other Income 28.93 0.00 0.00 210.81 0.00 0.00 210.81 0.00 0.00
PBIDT -321.35 -28.97 1009.25 543.84 74.73 627.74 543.84 74.73 627.74
Interest 38.47 -0.99 -3985.86 38.73 -0.75 -5264.00 38.73 -0.75 -5264.00
PBDT -359.82 -27.98 1185.99 505.11 75.48 569.20 505.11 75.48 569.20
Depreciation 0.14 0.14 0.00 0.57 1.51 -62.25 0.57 1.51 -62.25
PBT -359.96 -28.12 1180.09 504.54 73.97 582.09 504.54 73.97 582.09
TAX 177.24 19.70 799.70 177.24 19.70 799.70 177.24 19.70 799.70
Deferred Tax -0.19 -0.08 137.50 -0.19 -0.08 137.50 -0.19 -0.08 137.50
PAT -537.20 -47.82 1023.38 327.30 54.27 503.10 327.30 54.27 503.10
Equity 100.80 36.00 180.00 100.80 36.00 180.00 100.80 36.00 180.00
PBIDTM(%) -2.28 -3.83 -40.48 1.35 1.47 -8.20 1.35 1.47 -8.20

Supha Pharmachem Share Price

0.50 0.02 (4.17%)
22-Apr-2026 11:03 View Price Chart
Peers
Company Name CMP
Redington 226.80
Adani Enterprises 2230.00
Amrapali Industries 17.26
Rashi Peripheral 471.95
PDS 288.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×